Skip to playerSkip to main content
  • 5 years ago
Bharat Biotech has submitted Phase 3 clinical trial data for its Covid-19 vaccine, Covaxin, to the Drug Controller General of India (DCGI). The development comes nearly five months after Covaxin was authorised for emergency usage in the country.

#Covid19 #BharatBiotech #Covaxin

Category

🗞
News
Comments

Recommended